rxstat › Shortages › Gemfibrozil

Gemfibrozil shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Some Gemfibrozil products are in shortage in Canada (1 of 3 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.
Products affected
1 / 3
In shortage since
May 29, 2024
Reports on file
11
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.

Reports by product

Active shortage
TEVA-GEMFIBROZIL
600MG · TABLET · TEVA CANADA LIMITED
DIN 02142074 · since May 29, 2024, no end estimate · Disruption of the manufacture of the drug.
Resolved
TEVA-GEMFIBROZIL
600MG · TABLET · TEVA CANADA LIMITED
DIN 02142074 · ended Aug 17, 2023 · Disruption of the manufacture of the drug.
Resolved
TEVA-GEMFIBROZIL
600MG · TABLET · TEVA CANADA LIMITED
DIN 02142074 · ended Jul 14, 2021 · Demand increase for the drug.
Resolved
TEVA-GEMFIBROZIL
600MG · TABLET · TEVA CANADA LIMITED
DIN 02142074 · ended Jan 20, 2021 · Disruption of the manufacture of the drug.
Resolved
TEVA-GEMFIBROZIL
600MG · TABLET · TEVA CANADA LIMITED
DIN 02142074 · ended Jul 8, 2020 · Disruption of the manufacture of the drug.
Resolved
APO-GEMFIBROZIL
600MG · TABLET · APOTEX INC
DIN 01979582 · ended May 6, 2019 · Disruption of the manufacture of the drug.
Discontinued
APO-GEMFIBROZIL CAP 300MG USP
APOTEX INC
DIN 01979574
Resolved
APO-GEMFIBROZIL CAP 300MG USP
300 MG · CAPSULE · APOTEX INC
DIN 01979574 · ended Jun 3, 2019 · Disruption of the manufacture of the drug.
Discontinued
APO-GEMFIBROZIL CAP 300MG USP
300MG · CAPSULE · APOTEX INC
DIN 01979574
Resolved
TEVA-GEMFIBROZIL
600MG · TABLET · TEVA CANADA LIMITED
DIN 02142074 · ended May 1, 2018 · Disruption of the manufacture of the drug.
Discontinued
APO-GEMFIBROZIL
600MG · TABLET · APOTEX INC
DIN 01979582

What's happening

Gemfibrozil is currently affected by an active shortage report filed with Health Canada by TEVA CANADA LIMITED.

The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Gemfibrozil is classified under “LIPID MODIFYING AGENTS, PLAIN” (ATC C10AB).

Recent changes

Common questions

When will Gemfibrozil be back in stock in Canada?

Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.

Why is Gemfibrozil in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (lipid modifying agents, plain)

Partial shortageAtorvastatin11 of 64 reported products affected · est. return Jun 1, 2027Partial shortageCholestyramine Resin1 of 4 reported products affected · est. return Oct 3, 2027Partial shortageColestipol1 of 3 reported products affectedPartial shortageEzetimibe4 of 18 reported products affectedPartial shortageFluvastatin1 of 3 reported products affected · est. return Aug 31, 2026Partial shortageLovastatin2 of 10 reported products affected

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.